Apr 3, 2023
With a new CEO, a new subsidiary, a newly approved gene therapy and three R&D centers under construction on three different continents, change is coming fast for CSL Limited.
Nov 3, 2022
CSL Head of R&D and Chief Medical Officer Bill Mezzanotte is interviewed in the Australian Financial Review (Subscription Required)
Aug 19, 2022
CSL is taking action by setting 2030 carbon targets, CSL’s Chief Financial Officer says.
May 2, 2022
CSL is building the foundations for decentralised trials to be a core part of its research and development efforts within this decade, speeding up clinical development and opening up trials to more patients. (Subscription Required)
Mar 14, 2022
Lean into the momentum and innovation that the global pandemic inspired, CSL CEO Paul Perreault told attendees of The Economic Times Global Business Summit.
Nov 19, 2021
Leaders in science convened to discuss the most pressing topics in biotech, medicine and policy at the 2021 STAT Summit.
Sep 27, 2021
The CFO of global biotech company CSL, Joy Linton, has reached great heights by embracing ambiguity and saying yes to challenges.
Sep 6, 2021
CSL’s Chief Financial Officer Joy Linton talks to Business Chicks about playing the career long game.